Human rhinovirus (HRV) is a primary cause of mild upper respiratory infection in humans (24) . Although rhinovirus infection, as the "'common cold," is known to spread easily throughout human populations, only higher primates are susceptible (7, 20) ; thus, the virus possesses a narrow host range. This narrow host range is reflected in tissue culture in that the HRV replicates only in cells of primate origin.
We have successfully adapted HRV type 2 (HRV2) to grow in a nonpermissive cell line, L cells, which are of mouse origin. The only selective pressure used in adaptation was that of the nonpermissive host.
Host cell restriction of a virus can be the result of restriction at the cell surface or at any intracellular viral event. Restriction at the cell surface is generally due to the absence of appropriate receptors on the nonpermissive cells (11) , whereas intracellular restriction can include any viral event in which host factors are involved. Host range mutants of picornaviruses have been previously reported (23) ; changes in nonstructural proteins have also been described for host range mutants of other viruses (1, 21) . However, to our knowledge, no host range mutant of picornavirus has been reported in which nonstructural proteins have been altered.
We have studied the restriction of L cells on HRV2 (HRV2/H) and have also analyzed the biochemical changes of the mouse cell-adapted HRV2 (HRV2/L). The L-cell restriction on HRV2/H is found to occur at an intracellular level. The adapted virus, HRV2/L, which can overcome L-cell restriction, has altered nonstructural proteins, the functions of which have yet to be identified. Using different isolates of HRV2/L, we have shown that the alteration of these nonstructural proteins covaries with the host range of HRV2.
MATERIALS AND METHODS
Cells and viruses. HeLa cells (Flow Laboratories, Rockville, Md.) used with this work were handled as described by Korant et Purification of viral RNA and infectious RNA assay. Viral RNA was isolated from metrizamide gradientpurified virions. The virion preparations were disrupted in 10 mM Tris-hydrochloride-1 mM EDTA-0.1% lithium dodecyl sulfate (pH 7.5) and then digested with protease K (0.1 mg/ml) for 15 min at 37°C; viral RNA was chromatographed on an oligodeoxythymidylic acid-cellulose column as described by Aviv and Leder (2) .
The infectious RNA assay was performed on HeLa cell and L-cell monolayers (9) . Viral RNA in a buffer containing 0.14 M LiCl, 1 mM MgC12, 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), and 1.2 mg of DEAE-dextran per ml was absorbed on cells for 30 min and overlaid with agar. Plaques were scored after 3 days of incubation at 34°C.
Neutralization. The preparation of antiserum against HRV2/H and the procedure for neutralization were as described before (25) .
Assay of viral inhibitors. Effective doses of viral inhibitor were determined by yield reduction assays. HeLa cell monolayers, grown in 60-mm dishes, were infected with HRV2/H or HRV2/L at an MOI of 1 to 2. After absorption at 34°C for 30 min, growth medium, containing the desired concentration of test inhibitor, was pipetted onto each plate. Plates were incubated at 34°C for 24 h, after which the infected cells were frozen and thawed twice and the viral yields were determined by plaque assay on HeLa cells.
Determination of pH and heat stability. Growth medium without NaHCO3, but with 10 mM HEPES buffer, was adjusted to the desired pH with NaOH or HCL. Higher-titer virus was diluted into pH-adjusted medium and incubated at room temperature for 1 h. Virus was then titrated by plaque assay on HeLa cells.
Heat stability of the two viruses was determined by incubating high-titer virus at 45°C in medium containing 1% fetal bovine serum. Virus samples were taken out every 30 min and immediately diluted into cold medium. Virus titers of all samples were obtained by plaque assay. Capsid structure. Capsid structures of both HRV2/H and HRV2/L were examined by comparing virion antigenicity and pH and heat stability. Table 2 shows that HRV2/H, HRV2/L, and the various isolates of HRV2/L were neutralized to the same degree by antiserum made to HRV2/ H, suggesting that there is no detectable change of HRV2/L in its antigenicity.
Rhinoviruses differ from the other picornaviruses in the lability at low pH. HRV2/L retained the same pH lability as that of HRV2/H (Fig. 2) , and the various isolates of HRV2/L were also inactivated at low pH, although to a lesser extent than HRV2/L. Figure 3 indicates Figure 5 shows the slab gel electrophoresis pattern of viral proteins obtained from HRV2/H and HRV2/L-infected cells. The nomenclature of these viral proteins essentially follows that of poliovirus (13) . The three primary cleavage groups of polypeptides are 1A, X, and 1B. The only difference in nomenclature between poliovirus and HRV2 polypeptides lies in the X region; HRV2 proteins 58K, X (or 43K), and 38K correspond to poliovirus proteins 3b, Sb, and X. The gene order of HRV2 polypeptides is shown in the insert. Among the large viral proteins, one major difference between HRV2/H and HRV2/L was observed. HRV2/H was found to make a viral protein with a molecular weight of 43,000, whereas HRV2/L made a corresponding protein with a molecular weight of 45,000. This alteration was observed whether the viral proteins of HRV2/L were made in HeLa or L cells (lanes 1 and 3, Fig. 5 To further confirm that X(45) of HRV2/L and X(43K) of HRV2/H are equivalent proteins, and also to determine whether any additional differences exist among pairs of other major proteins of the two viruses, limited proteolysis of the major precursor polypeptides (1A, 1B, 2, X, and 38K) was performed as described in Materials and Methods. Figure 6 shows SDS-PAGE slab gel patterns for each pair of equivalent proteins, before and after proteolysis, at two concentrations of V8 protease. No detectable differences in peptide patterns were observed between the pairs of digested proteins 1A, 1B, 2, and 38K. However, the pattern of digested X(45K) of HRV2/L differed from that of X(43K) of HRV2/ H in yielding three cleavage products with higher mobilities (Fig. 6D) .
These findings from the limited proteolysis of isolated polypeptides by V8 protease confirmed that X(43K) and X(45K) are related proteins with minor differences. The V8 digests also indicated no detectable differences between the other pairs of equivalent proteins.
Covariation of X(45K) and 9K protein with host range. Figure 7 is an autoradiogram of the viral proteins in HeLa cells infected by various host range mutant isolates of HRV2/L.
To be certain that host cell protein synthesis was completely inhibited, the labeling condition was changed; [35S]methionine was added from 8.5 to 14 h after infection. It was clear that X(45K) was made by all HRV2/L isolates and was absent only among the proteins made by HRV2/H (see lanes 1 and 10). Thus, it can be concluded that X(45) is a viral protein which covaries with the host range of the virion.
In addition, all HRV2/L isolates made a 9K protein which was absent in HRV2/H-infected cells (Fig. 8) . Thus, the 9K protein also covaried with the host range of the virion.
Precursor proteins of X(43K) and X(45K) also have different molecular weights. Although ZnCl2 is known to be an inhibitor of HRV protein cleavage, it inhibits cleavage of the HRV2 structural precursor polyprotein to a greater extent than it affects the cleavage of nonstructural precursor proteins (4). Thus, when the viral proteins are labeled in the presence of ZnCl2, it is possible to observe the precursor of X(43K) clearly on the slab gel. Figure 9 shows such an experiment in which the structural proteins were not labeled and proteins of the X region could be clearly identified. It was found that in HRV2/Hinfected cells the precursor of X(43K) is 58K and in HRV2/L-infected cells the precursor of X(45K) is 60K. Thus, the difference of molecular weights between proteins 43K and 45K is also evident in the corresponding precursor proteins. 418 YIN AND LOMAX single amino acid substitution which decreases the affinity of these proteins for negatively charged SDS as reported for polio -virus structural proteins (12) .
We have no information on the 9K protein at the present time; its small size makes it difficult to map its gene order by the pactamycin mapping procedure.
It is interesting that X protein is the product from the only region of the picornaviral genome whose function is still unknown. It had been proposed to be the viral protease (14) , although a recent report indicated that 7C instead of X(43K) (or its cleavage product) plays an essential role in proteolytic activity (10) . Guanidine sensitivity has been mapped in this X protein in an aphthovirus (22) , thus indicating the possible involvement of this protein with viral RNA synthesis. Our data indicate that the X region may be involved with viral RNA synthesis, although the detail of its function is yet to be defined, and also that a host factor(s) plays a role in its function. One of the many possible roles of this membrane protein could be the binding and compartmentalization of the various components of viral RNA synthesis, such as polymerase, VpG, and host factors.
